Provided by Tiger Trade Technology Pte. Ltd.

3D MEDICINES

3.880
-0.170-4.20%
Volume:53.50K
Turnover:210.45K
Market Cap:1.00B
PE:-5.20
High:4.020
Open:4.010
Low:3.850
Close:4.050
52wk High:10.020
52wk Low:2.710
Shares:258.00M
HK Float Shares:258.00M
Volume Ratio:0.39
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.746
ROE:-25.33%
ROA:-5.25%
PB:1.23
PE(LYR):-5.20
PS:1.97

Loading ...

BRIEF-3D Medicines Inc Says Envafolimab Supplemental Application Accepted By NMPA

Reuters
·
Feb 09

3D MEDICINES Receives NMPA Acceptance for Full Approval Application of Envida®

Stock News
·
Feb 09

3D Medicines Inc. (Stock Code: 1244) Announces NMPA Acceptance for Envafolimab Conditional-to-Regular Approval Application

Bulletin Express
·
Feb 09

3D Medicines Inc - Envafolimab Supplemental Application for Conditional-to-Regular Approval Transition Accepted by Nmpa

THOMSON REUTERS
·
Feb 09

BRIEF-3D Medicines Inc Says Zhang Jing Resigns As CFO

Reuters
·
Jan 12

3D MEDICINES (01244) Appoints Lu Xiao Hao as Chief Financial Officer

Stock News
·
Jan 12

3D Medicines Inc. Appoints Lu Xiaohao as Chief Financial Officer

Reuters
·
Jan 12

3D Medicines Inc - Zhang Jing Resigns as CFO

THOMSON REUTERS
·
Jan 12

BRIEF-3D Medicines Says New Drug Application For First-Line Treatment Of Biliary Tract Cancer Of Envafolimab Accepted

Reuters
·
Jan 09

3D MEDICINES (01244): New Drug Application for ENVAFOLIMAB as First-Line Treatment for Biliary Tract Cancer Accepted by NMPA

Stock News
·
Jan 09

3D Medicines Inc - New Drug Application for First-Line Treatment of Biliary Tract Cancer of Envafolimab Accepted by Nmpa

THOMSON REUTERS
·
Jan 09

BRIEF-3D Medicines Says Envafoimab Granted Orphan Drug Designation

Reuters
·
Dec 23, 2025

3D MEDICINES (01244): ENVAFOLIMAB® Granted Orphan Drug Designation for Gastric and Gastroesophageal Junction Cancer

Stock News
·
Dec 22, 2025

3D Medicines Inc - Envafoimab Granted Orphan Drug Designation

THOMSON REUTERS
·
Dec 22, 2025

3D Medicines Inc - Designation for Treatment of Gastric Cancer and - Gastro-Esophageal Junction Cancer Indications by China Nmpa

THOMSON REUTERS
·
Dec 22, 2025

3D Medicines Inc. (01244) Publishes November 2025 Monthly Return on Movements in Share Capital

Bulletin Express
·
Dec 04, 2025

Does 3D Medicines (HKG:1244) Have A Healthy Balance Sheet?

Simply Wall St.
·
Nov 19, 2025

3D Medicines Inc. (01244) Announces No Change in Share Capital for October 2025

Bulletin Express
·
Nov 05, 2025

Hong Kong Stock Alert | 3D MEDICINES (01244) Surges Over 10% as Self-Developed Next-Generation Precision Nuclear Medicine Completes First Patient Dosing, Nuclear Medicine Market Shows Enormous Potential

Stock News
·
Sep 09, 2025

3D Medicines Narrows Loss in H1 as Revenue Edges Up

MT Newswires Live
·
Sep 01, 2025